BPC-157, TB-500, GHK-Cu 30mg (Glow Blend)

BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg

(30mg Total Glow Blend)

Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg

Mechanisms and Synergy

BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling. It improves healing of tendons, muscles, and the intestine in preclinical models.

TB-500 (Thymosin Beta-4): A 43-amino-acid actin-sequestering peptide that promotes tissue regeneration through cell migration, angiogenesis (via upregulation of VEGF) and anti-inflammatory effects. It mobilizes progenitor cells and accelerates the repair of the myocardium, dermis, and connective tissue.

GHK-Cu: A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that stimulates wound healing, collagen synthesis, and hair growth. It modulates gene expression associated with tissue remodeling and acts as an antioxidant and anti-inflammatory by regulating TGF-β and metalloproteinases.

Synergistic Benefits:

Combined research with BPC-157, TB-500, and GHK-Cu could offer synergistic tissue regeneration and anti-inflammatory benefits by simultaneously activating multiple repair pathways:

Angiogenesis: TB-500 and BPC-157 both promote VEGF-mediated neovascularization, while GHK-Cu increases the proliferation of endothelial cells.

Cellular migration and matrix remodeling: TB-500 improves actin polymerization and cellular motility; GHK-Cu and BPC-157 stimulate ECM production and fibroblast activity.

Anti-inflammatory modulation: All three reduce oxidative stress and cytokine-induced inflammation, which may improve healing in chronic or complex injuries.

This multifactorial synergy suggests an improved efficacy in musculoskeletal, dermatological, and postoperative applications.